Business Division Results

Fiscal 2009

Annual Report 2009

Business Divisions' Sales
in € million	Q4 2009	Q4 2008	Change in %	2009	2008	Change in %
WACKER SILICONES	325.1	297.1	9	1,238.8	1,408.6	-12
WACKER POLYMERS	164.8	185.9	-11	743.8	867.9	-14
WACKER FINE CHEMICALS*	28.6	23.0	24	104.9	97.7	7
WACKER POLYSILICON	268.5	239.1	12	1,121.2	828.1	35
Siltronic	184.4	303.6	-39	637.5	1,360.8	-53
Corporate functions / Other	32.7	65.1	-50	180.8	265.4	-32
Consolidation	-69.3	-115.1	-40	-307.7	-530.4	-42
Group Sales	934.8	998.7	-6	3,719.3	4,298.1	-13
* since March 1, 2010 WACKER BIOSOLUTIONS

Business Divisions' EBIT
in € million	Q4 2009	Q4 2008	Change in %	2009	2008	Change in %
WACKER SILICONES	-32.4	-38.6	-16	33.5	86.3	-61
WACKER POLYMERS	1.3	-10.1	-113	77.8	64.9	20
WACKER FINE CHEMICALS*	-1.2	-0.6	100	4.7	6.0	-22
WACKER POLYSILICON	96.6	90.6	7	414.1	349.8	18
Siltronic	-63.7	-36.5	75	-414.7	193.8	>-100
Corporate functions / Other	-59.0	-17.2	>100	-89.9	-51.7	74
Consolidation	-2.2	-1.2	83	1.3	-1.2	>-100
Group EBIT	-60.6	-13.6	>100	26.8	647.9	-96
* since March 1, 2010 WACKER BIOSOLUTIONS

Business Divisions' EBITDA
in € million	Q4 2009	Q4 2008	Change in %	2009	2008	Change in %
WACKER SILICONES	23.6	-18.4	>-100	157.9	167.9	-6
WACKER POLYMERS	10.2	4.2	143	117.2	108.9	8
WACKER FINE CHEMICALS*	0.7	0.3	133	9.9	9.2	8
WACKER POLYSILICON	130.2	115.2	13	520.8	422.0	23
Siltronic	-22.6	23.2	>-100	-162.4	357.3	-145
Corporate functions / Other	-45.1	-4.6	>100	-38.0	-8.9	>100
Consolidation	-2.2	-1.2	83	1.3	-1.2	>-100
Group EBITDA	94.8	118.7	-20	606.7	1,055.2	-43
* since March 1, 2010 WACKER BIOSOLUTIONS

Contact & Services

Note

This website contains forward looking statements based on assumptions and estimates of WACKER's Executive Board. Although we assume the expectations in these forward looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward looking statements. Factors that may cause such discrepancies include, among other things, changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update the forward looking statements, nor does it assume the obligation to do so.